Thus, our study identifies a novel mechanism mediated by TRIB2/AP4/P21 axis in regulating cellular senescence, and suggests that TRIB2 might be a new target in clinical practice for CRC treatment. Here, CDKN1A is linked to colorectal carcinoma.